) The Protein Microchemistry Core assists cancer researchers with all aspects relating to the isolation, purification, identification and production of peptides and proteins. Forty Cancer Center investigators from 9 of the 10 Cancer Programs have utilized the Protein Microchemistry Core since 1996. In 1999, the Protein Microchemistry Core facilities at UCHSC and the National Jewish Center were combined. The combination of these Cores resulted in the doubling of the use of microsequencing facilities over 1998 values and tripled the use of mass spectrometry services. Restructuring of the Core also added peptide synthesis as a new Core service. This service already has a significant usage rate and demand appears to be increasing. Increased use of the Core by investigators interested problems of protein structure and analysis of complex protein mixtures led to its reorganization and expansion. The expanded version of the Protein Microchemistry Core is significantly enhanced through the addition of state-of-the-art mass spectrometry, an upgrade in Edman sequencing hardware and the addition of peptide synthesis. Several mass spectrometers, including 3 electrospray ionization (ESI) systems and a matrix-assisted laser desorption ionization (MALDI) mass spectrometer combined with a Perkin Elmer Procise 494 Edman sequencer will ensure that researchers have access to the most powerful hardware currently available. The core also provides the expertise, technical resources and collaborative interactions to ensure that these instruments are optimally employed in solving the problems of the user base. The Protein Microchemistry Core, directed by Mark Duncan Ph.D., is composed of two facilities: the Proteomics Unit and the Protein Structure Unit. The Core occupies space on the University of Colorado Health Sciences Center (UCHSC) campus, and at National Jewish Center (NJC). The Core has access to all the necessary equipment to realize its objectives, but the hiring of some additional staff is necessary.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA046934-14
Application #
6491219
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1988-03-01
Project End
2006-01-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Altieri, Lisa; Miller, Kimberly A; Huh, Jimi et al. (2018) Prevalence of sun protection behaviors in Hispanic youth residing in a high ultraviolet light environment. Pediatr Dermatol 35:e52-e54
Kwak, Jeff W; Laskowski, Jennifer; Li, Howard Y et al. (2018) Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res 78:143-156
Hoefert, Jaimee E; Bjerke, Glen A; Wang, Dongmei et al. (2018) The microRNA-200 family coordinately regulates cell adhesion and proliferation in hair morphogenesis. J Cell Biol 217:2185-2204
Kim, Seongsoon; Park, Donghyeon; Choi, Yonghwa et al. (2018) A Pilot Study of Biomedical Text Comprehension using an Attention-Based Deep Neural Reader: Design and Experimental Analysis. JMIR Med Inform 6:e2
Sclafani, Robert A; Hesselberth, Jay R (2018) O Cdc7 kinase where art thou? Curr Genet 64:677-680
Shearn, Colin T; Orlicky, David J; Petersen, Dennis R (2018) Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease. Exp Mol Pathol 104:1-8
Kim, Jihye; Yoo, Minjae; Shin, Jimin et al. (2018) Systems Pharmacology-Based Approach of Connecting Disease Genes in Genome-Wide Association Studies with Traditional Chinese Medicine. Int J Genomics 2018:7697356
Riemondy, Kent A; Gillen, Austin E; White, Emily A et al. (2018) Dynamic temperature-sensitive A-to-I RNA editing in the brain of a heterothermic mammal during hibernation. RNA 24:1481-1495
Petersen, Dennis R; Orlicky, David J; Roede, James R et al. (2018) Aberrant expression of redox regulatory proteins in patients with concomitant primary Sclerosing cholangitis/inflammatory bowel disease. Exp Mol Pathol 105:32-36
Couts, Kasey L; Bemis, Judson; Turner, Jacqueline A et al. (2018) ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms. Mol Cancer Ther 17:222-231

Showing the most recent 10 out of 1634 publications